Published in Cancer Weekly, April 2nd, 2002
The findings were published in the February 26, 2002, edition of the journal Cancer Cell by scientists at St. Jude Children's Research Hospital. James R. Downing, MD, chairman of the St. Jude Pathology department, led the research.
The study is the first to give scientists a way to control the genetic expression of specific cellular targets. The method, known as modeling, involved implanting into mice a mutated protein considered a trigger of AML. Though modeling is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.